en
Scientific article
English

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

Published inAlzheimer's Research and Therapy, vol. 10, no. 1, 64
Publication date2018
Abstract

There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer's disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery (EMIF-AD MBD) study. In this report we describe the design of the study, the methods used and the characteristics of the participants.

Citation (ISO format)
BOS, Isabelle et al. The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics. In: Alzheimer’s Research and Therapy, 2018, vol. 10, n° 1, p. 64. doi: 10.1186/s13195-018-0396-5
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal1758-9193
400views
0downloads

Technical informations

Creation10/24/2018 11:17:00 AM
First validation10/24/2018 11:17:00 AM
Update time03/15/2023 4:01:24 PM
Status update03/15/2023 4:01:22 PM
Last indexation02/12/2024 11:39:14 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack